The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301483 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Christina Kronberger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department for Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Quality of Life, Hypertension, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical scientific fund of the Major of Vienna.
Abstract (Originalsprache)
Introduction
Patients with pulmonary hypertension (PH) have an impaired functional capacity and poor health-related quality of life (HRQoL). The one-minute sit-to-stand test (1-min STST) can be used for the assessment of functional capacity.
Aims
Our aim was to evaluate the 1-min STST performance and its association with patient-reported HRQoL in patients with PH.
Methods
We prospectively assessed functional capacity in 98 PH patients (mean age 66 ± 15 years, 55% female) using the 1-min STST. Patients had to stand up and sit down from a chair as many times as possible within one minute. Patients’ HRQoL was evaluated with the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) questionnaire, which consists of the three subcategories symptoms, activities and quality of life (QoL).
Results
We observed a significant correlation of the 1-min STST performance with all HRQoL subcategories assessed with the CAMPHOR questionnaire: A lower number of 1-min STST repetitions correlated with more symptoms (r s = -.398, p < .001), worse functioning (r s = -.551, p < .001) and a decreased QoL (r s = -.407, p < .001). Furthermore, in the multivariable linear regression analysis, adjusted for age, sex, body mass index (BMI) and mean pulmonary artery pressure (mPAP), lower 1-min STST performance was an independent predictor for worse symptoms (est. β = -0.112, p = .003), activities (est. β = -0.198, p < .001) and QoL (est. β = -0.130, p < .001) assessed with the CAMPHOR questionnaire.
Conclusion
Our results indicate that regardless of age, sex, BMI and mPAP the 1-min STST performance is associated with all CAMPHOR HRQoL subcategories in patients with PH. Therefore, the 1-min STST performance might be a new option to assess functional capacity correlated to HRQoL in patients with PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department for Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
- Galen Research, Manchester, United Kingdom.
- Department for Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Robin Willixhofer, Roya Anahita Mousavi, Roza Badr Eslam
Förderung
- Medical scientific fund of the Major of Vienna
Zitieren
APA
Kronberger, C., Willixhofer, R., Mousavi, R. A., Grzeda, M. T., Litschauer, B., Krall, C., & Badr Eslam, R. (2024). The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension. PLOS ONE. https://doi.org/10.1371/journal.pone.0301483
Vancouver
Kronberger C, Willixhofer R, Mousavi RA, Grzeda MT, Litschauer B, Krall C, et al. The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension. PLOS ONE. 2024. doi:10.1371/journal.pone.0301483
BibTeX
@article{Kronberger2024,
author = {Kronberger, Christina and Willixhofer, Robin and Mousavi, Roya Anahita and Grzeda, Mariusz Tadeusz and Litschauer, Brigitte and Krall, Christoph and Badr Eslam, Roza},
title = {The one-minute sit-to-stand-test performance is associated with health-related quality of life in patients with pulmonary hypertension},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301483}
}
EUVIMED